Covered recipient · General Payments record
ESPERANZA ARCILA KHARBOUCH
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Family
General Payments · PY2021–2024
$4,247.69
- Reported across 205 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $616.20 | 28 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $239.87 | 12 |
| JAZZ PHARMACEUTICALS INC. | $79.17 | 3 |
| UCB, Inc. | $63.47 | 2 |
| Neurelis, Inc. | $56.52 | 3 |
| Otsuka America Pharmaceutical, Inc. | $47.38 | 2 |
| Lilly USA, LLC | $42.75 | 2 |
| LivaNova USA, Inc. | $35.88 | 2 |
| PFIZER INC. | $27.41 | 1 |
| SK Life Science, Inc. | $23.75 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (28)
Sorted by paying entity, then date · as published by CMS
Program year 2024 202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $31.19 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458356 | CMS |
| ABBVIE INC. | $23.35 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458358 | CMS |
| ABBVIE INC. | $5.41 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458360 | CMS |
| ABBVIE INC. | $5.65 | 06/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458362 | CMS |
| ABBVIE INC. | $16.66 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458364 | CMS |
| ABBVIE INC. | $23.72 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458366 | CMS |
| ABBVIE INC. | $23.32 | 07/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458368 | CMS |
| ABBVIE INC. | $27.74 | 07/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458370 | CMS |
| ABBVIE INC. | $24.22 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458372 | CMS |
| ABBVIE INC. | $20.94 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458374 | CMS |
| ABBVIE INC. | $13.67 | 08/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458376 | CMS |
| ABBVIE INC. | $24.00 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107458378 | CMS |
| JAZZ PHARMACEUTICALS INC. | $25.54 | 06/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151309212 | CMS |
| JAZZ PHARMACEUTICALS INC. | $30.03 | 07/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151309208 | CMS |
| JAZZ PHARMACEUTICALS INC. | $23.60 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151309210 | CMS |
| Lilly USA, LLC | $17.49 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135658999 | CMS |
| Lilly USA, LLC | $25.26 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135666628 | CMS |
| LivaNova USA, Inc. | $15.46 | 06/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152801593 | CMS |
| LivaNova USA, Inc. | $20.42 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1152801601 | CMS |
| Neurelis, Inc. | $18.99 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665899 | CMS |
| Neurelis, Inc. | $16.63 | 06/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665901 | CMS |
| Neurelis, Inc. | $20.90 | 07/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145665903 | CMS |
| Otsuka America Pharmaceutical, Inc. | $18.42 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119111717 | CMS |
| Otsuka America Pharmaceutical, Inc. | $28.96 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119111719 | CMS |
| PFIZER INC. | $27.41 | 07/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131916783 | CMS |
| SK Life Science, Inc. | $23.75 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154116789 | CMS |
| UCB, Inc. | $33.75 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143091460 | CMS |
| UCB, Inc. | $29.72 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1143091462 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.